Sinopharm Group Co. Ltd
🇩🇪XFRA.X2SGermanyNot reported
Price€1.64-0.02 (-1.2%)
Latest anomalies
Neutral 1 detected in the last 120 days
- High: 0
- Medium: 1
- Low: 0
52-week low: the price is trading close to this level
Receivables turnover: a sudden spike above its trailing quarter average
Free with a Finzer account.
Profile
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- CNE100000FN7
- CUSIP
- Not reported
Company
- Employees
- 0
- Headquarters
- Shanghai, Germany
Market
- Shares outstanding
- 1.3B
- Market cap
- €2.2B
Highlights
No high and low reported for today's session.
- Market cap
- €2.2B
- EPS LTM
- CN¥3.47calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- CN¥290.74B+100.63%up year on year
- Net income
- CN¥4.66B+115.45%up year on year
- Gross margin
- 100%0%unchanged year on year
- Free cash flow
- CN¥59.02B+9.78%up year on year
Latest news
News is not sourced for this exchange.
Business summary
Sinopharm Group Co. Ltd is listed on Frankfurt Stock Exchange (Germany) under the ticker X2S. Its market capitalisation is €2.2B, from 1.3B shares outstanding, as of . Across the 252 trading sessions to the shares traded between €1.64 and €2.37, and the last close of €1.64 sits 0% of the way up that range. The company is headquartered in Shanghai, Germany. This is the Frankfurt Stock Exchange listing of Sinopharm Group Co. Ltd; its primary listing is X2S on Stuttgart Stock Exchange.
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices Distribution segment distributes medical devices, as well as provides installation and maintenance services. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the distribution of laboratory supplies; manufacture and distribution of chemical reagents; and production and sale of pharmaceutical products. The company rents and manages properties; distributes medical instruments and equipment, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. It also manages medical project investment, consulting, and technology training activities; and manufactures medicines. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.